Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic Impairment
- First Posted Date
- 2009-01-26
- Last Posted Date
- 2019-09-12
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00828932
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects
- First Posted Date
- 2009-01-26
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00828581
- Locations
- 🇺🇸
CRI Worldwide - Lourdes Hospital, Willingboro, New Jersey, United States
A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2008-11-20
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT00794781
Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
Phase 2
Completed
- Conditions
- Thyroid Cancer
- Interventions
- First Posted Date
- 2008-11-02
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 117
- Registration Number
- NCT00784303
Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Phase 2
Completed
- Conditions
- Acute Myelogenous LeukemiaMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2011-08-08
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT00760084
- Locations
- 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States
A Study of Eritoran (E5564) Administered IV Over 14 Days Prior to and During Bone Marrow Engraftment in BMT Patients Who Have Received Myeloablative Conditioning Treatment and Are Receiving Bone Marrow or Stem Cells From Matched Related Donors
- First Posted Date
- 2008-09-22
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00756912
- Locations
- 🇺🇸
Case Western Reserve University School of Medicine, Cleveland, Ohio, United States
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
Phase 3
Terminated
- Conditions
- Down SyndromeCognitive Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-09-17
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT00754013
- Locations
- 🇺🇸
Road Runner Research, San Antonio, Texas, United States
🇺🇸NeuroScience, Inc., Herndon, Virginia, United States
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
Phase 3
Terminated
- Conditions
- Down SyndromeCognitive Dysfunction
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-09-17
- Last Posted Date
- 2018-04-23
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT00754052
- Locations
- 🇺🇸
Road Runner Research, San Antonio, Texas, United States
🇺🇸Neuroscience, Inc, Herndon, Virginia, United States
Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures
- First Posted Date
- 2008-08-14
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 1218
- Registration Number
- NCT00735397
Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease
Phase 4
Withdrawn
- Conditions
- Severe Alzheimer's Disease
- Interventions
- First Posted Date
- 2008-07-08
- Last Posted Date
- 2012-12-10
- Lead Sponsor
- Eisai Inc.
- Registration Number
- NCT00711204
- Locations
- 🇺🇸
Kettlie Joseph Daniels, M.D. Inc., Toledo, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath